Join or start a Project to collaborate with others on new applications of
Technologies are open to all Therapoid members, subject to the our Terms of Service. You can utilize this technology in your research free of charge with the collaborators on this platform.
oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells
Open Therapeutics™; Research Institute Nationwide Children's Hospital
Engineered oHSV lytically destroy cancer cells and stimulates the immune system to act against cancer cells.Tags: cancer immunotherapy virus oncolytics 5 projects